Literature DB >> 29380297

Epidemiology of fungal infections in China.

Min Chen1,2, Yuan Xu1,2, Nan Hong1,2, Yali Yang1, Wenzhi Lei1, Lin Du1, Jingjun Zhao3, Xia Lei4, Lin Xiong5, Langqi Cai6, Hui Xu7, Weihua Pan8, Wanqing Liao9.   

Abstract

With the increasing number of immunocompromised hosts, the epidemiological characteristics of fungal infections have undergone enormous changes worldwide, including in China. In this paper, we reviewed the existing data on mycosis across China to summarize available epidemiological profiles. We found that the general incidence of superficial fungal infections in China has been stable, but the incidence of tinea capitis has decreased and the transmission route has changed. By contrast, the overall incidence of invasive fungal infections has continued to rise. The occurrence of candidemia caused by Candida species other than C. albicans and including some uncommon Candida species has increased recently in China. Infections caused by Aspergillus have also propagated in recent years, particularly with the emergence of azole-resistant Aspergillus fumigatus. An increasing trend of cryptococcosis has been noted in China, with Cryptococcus neoformans var. grubii ST 5 genotype isolates as the predominant pathogen. Retrospective studies have suggested that the epidemiological characteristics of Pneumocystis pneumonia in China may be similar to those in other developing countries. Endemic fungal infections, such as sporotrichosis in Northeastern China, must arouse research, diagnostic, and treatment vigilance. Currently, the epidemiological data on mycosis in China are variable and fragmentary. Thus, a nationwide epidemiological research on fungal infections in China is an important need for improving the country's health.

Entities:  

Keywords:  China; epidemiology; fungi; infection

Mesh:

Year:  2018        PMID: 29380297     DOI: 10.1007/s11684-017-0601-0

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  201 in total

Review 1.  Pneumocystis pneumonia.

Authors:  Charles F Thomas; Andrew H Limper
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

Review 2.  Current topics of tinea capitis in China.

Authors:  Jin Yu; Ruoyu Li; Glenn Bulmer
Journal:  Nihon Ishinkin Gakkai Zasshi       Date:  2005

3.  Invasive candidiasis in intensive care units in China: a multicentre prospective observational study.

Authors:  Fengmei Guo; Yi Yang; Yan Kang; Bin Zang; Wei Cui; Bingyu Qin; Yingzhi Qin; Qiang Fang; Tiehe Qin; Dongpo Jiang; Weiqin Li; Qin Gu; Hongsheng Zhao; Dawei Liu; Xiangdong Guan; Jianguo Li; Xiaochun Ma; Kaijiang Yu; Dechang Chan; Jing Yan; Yaoqing Tang; Wei Liu; Ruoyu Li; Haibo Qiu
Journal:  J Antimicrob Chemother       Date:  2013-03-29       Impact factor: 5.790

4.  Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene.

Authors:  Shawn R Lockhart; João P Frade; Kizee A Etienne; Michael A Pfaller; Daniel J Diekema; S Arunmozhi Balajee
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

5.  Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.

Authors:  Gloria M González; Rogelio de J Treviño-Rangel; José P Palma-Nicolás; César Martínez; J Gerardo González; Jacobo Ayala; Amílcar Caballero; Rayo Morfín-Otero; E Rodríguez-Noriega; Fernando Velarde; Elba P Ascencio; Juan C Tinoco; Jorge A Vázquez; Manuel A Cano; Nidia León-Sicairos; Rocío González; Joaquín Rincón; Miguel A Elías; Alexandro Bonifaz
Journal:  J Antimicrob Chemother       Date:  2013-07-18       Impact factor: 5.790

6.  Penicillium marneffei infection: an emerging disease in mainland China.

Authors:  Yongxuan Hu; Junmin Zhang; Xiqing Li; Yabo Yang; Yong Zhang; Jianchi Ma; Liyan Xi
Journal:  Mycopathologia       Date:  2012-09-17       Impact factor: 2.574

7.  [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].

Authors:  Bin Cao; Hui Wang; Lin Wu; Wen-jia Sun; Fang Li; Ying-mei Liu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2008-07-22

8.  Pulmonary fungus ball caused by Penicillium capsulatum in a patient with type 2 diabetes: a case report.

Authors:  Min Chen; Jos Houbraken; Weihua Pan; Chao Zhang; Hao Peng; Lihui Wu; Deqiang Xu; Yiping Xiao; Zhilong Wang; Wanqing Liao
Journal:  BMC Infect Dis       Date:  2013-10-23       Impact factor: 3.090

9.  Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.

Authors:  Jiajia Chen; Qing Yang; Jianrong Huang; Lanjuan Li
Journal:  Int J Med Sci       Date:  2013-09-18       Impact factor: 3.738

10.  Severe Chromoblastomycosis-Like Cutaneous Infection Caused by Chrysosporium keratinophilum.

Authors:  Juhaer Mijiti; Bo Pan; Sybren de Hoog; Yoshikazu Horie; Tetsuhiro Matsuzawa; Yilixiati Yilifan; Yong Liu; Parida Abliz; Weihua Pan; Danqi Deng; Yun Guo; Peiliang Zhang; Wanqing Liao; Shuwen Deng
Journal:  Front Microbiol       Date:  2017-01-25       Impact factor: 5.640

View more
  31 in total

1.  Candida albicans CHK1 gene from two-component system is essential for its pathogenicity in oral candidiasis.

Authors:  Yujie Zhou; Lei Cheng; Binyou Liao; Yangyang Shi; Yulong Niu; Chengguang Zhu; Xingchen Ye; Xuedong Zhou; Biao Ren
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-26       Impact factor: 4.813

Review 2.  Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents.

Authors:  Sahar Hasim; Jeffrey J Coleman
Journal:  Future Med Chem       Date:  2019-04-17       Impact factor: 3.808

3.  Epidemiology of Onychomycosis in Chinese Mainland: A 30-year Retrospective Study.

Authors:  Ge Song; Meijie Zhang; Weida Liu; Guanzhao Liang
Journal:  Mycopathologia       Date:  2022-07-10       Impact factor: 3.785

4.  Clinical analysis in immunocompetent and immunocompromised patients with pulmonary cryptococcosis in western China.

Authors:  Junyan Qu; Xiaoli Zhang; Yang Lu; Xijiao Liu; Xiaoju Lv
Journal:  Sci Rep       Date:  2020-06-10       Impact factor: 4.379

5.  Molecular identification of Cryptococcus gattii from cerebrospinal fluid using single-cell sequencing: A case study.

Authors:  Min Chen; Nan Hong; Shan Hu; Peng Wang; HongZhi Guan; Meng Xiao; Xinlin Zhu; Abdullah M S Al-Hatmi; Zhe Zhou; Lei Gao; Teun Boekhout; Jianping Xu; Yingchun Xu; Wanqing Liao; Ying Yang
Journal:  J Infect       Date:  2020-06-23       Impact factor: 6.072

6.  Effective treatment using itraconazole combined with terbinafine in the treatment of nasal sporotrichosis: A case report.

Authors:  Keying Guo; Shenghua Wang; Zhenying Wang; Li Zhang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

7.  Fungal Diseases in Taiwan-National Insurance Data and Estimation.

Authors:  Yu-Shan Huang; David W Denning; Shu-Man Shih; Chao A Hsiung; Un-In Wu; Hsin-Yun Sun; Pao-Yu Chen; Yee-Chun Chen; Shan-Chwen Chang
Journal:  J Fungi (Basel)       Date:  2019-08-21

Review 8.  Pharmacotherapy of Lower Respiratory Tract Infections in Elderly-Focused on Antibiotics.

Authors:  Yang Liu; Yan Zhang; Wanyu Zhao; Xiaolei Liu; Fengjuan Hu; Birong Dong
Journal:  Front Pharmacol       Date:  2019-10-31       Impact factor: 5.810

9.  Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China.

Authors:  Zhang-Rui Zeng; Gang Tian; Yin-Huan Ding; Kui Yang; Jin-Bo Liu; Jian Deng
Journal:  BMC Infect Dis       Date:  2019-11-07       Impact factor: 3.090

10.  A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China.

Authors:  Zhangrui Zeng; Yinhuan Ding; Gang Tian; Kui Yang; Jian Deng; Guangrong Li; Jinbo Liu
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-14       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.